Congleton Jon's Form 4 filing
Mineralys Therapeutics, Inc. (MLYS) · filed Jan 13, 2026
- Accession no.
- 0001644975-26-000002
- Filed
- Jan 13, 2026
- Trade date
- Jan 12, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $529.7K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Congleton JonCIK 0001644975 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Common Stock | SSaleDisposed | −9,119 | $32.21 | −$293,722.99 | 646,268 | Direct | |
| Jan 12, 2026 | Common Stock | SSaleDisposed | −7,117 | $33.15 | −$235,928.55 | 639,151 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.